Elanco Animal Health Inc at Leerink Global Healthcare Conference Transcript
Alright, great, thank you everybody for joining. Day 3 of the Leerink Global Healthcare conference. I'm joined by Elanco CFO Bob VanHimbergen; Head of the US Business, Bobby Modi. We've got Tiffany Kanega from IR in the audience, and Eric Seremet from finance in the audience. Very happy to have you all here. And Bobby, you want to kick us off with some opening remarks?
Yeah, no, great. Hey, I appreciate it. Thanks for having us. So listen, as I think about Elanco and where we are, we continue to operate with just a tremendous amount of momentum. We ended Q4 on a strong note and really beat our guide, really across the board on revenue earnings, EPS, cash flow came in much stronger, so we were able to delever even a little bit lower than what we anticipated, and it's really driven a lot from our basket of innovation.
We ended the year with $892 million of revenue from that basket, which is above what we had guided as well.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
